Evidence map›Paper›PMID 34721719›Full record

ArticleNuclear medicine and molecular imaging2021

Dheeratama Siripongsatian, Chetsadaporn Promteangtrong, Anchisa Kunawudhi, Peerapon Kiatkittikul, Chanisa Chotipanich

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. The comparative utility of FAPI-based PET radiotracers over [American journal of nuclear medicine and molecular imaging · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dheeratama SiripongsatianNational Cyclotron and PET Centre, Chulabhorn Hospital, Chulabhorn Royal Academy, Kamphangpetch 6 Road, Laksi Bangkok, 10210 Thailand.ORCID 0000-0001-7914-7141
Chetsadaporn PromteangtrongNational Cyclotron and PET Centre, Chulabhorn Hospital, Chulabhorn Royal Academy, Kamphangpetch 6 Road, Laksi Bangkok, 10210 Thailand.
Anchisa KunawudhiNational Cyclotron and PET Centre, Chulabhorn Hospital, Chulabhorn Royal Academy, Kamphangpetch 6 Road, Laksi Bangkok, 10210 Thailand.
Peerapon KiatkittikulNational Cyclotron and PET Centre, Chulabhorn Hospital, Chulabhorn Royal Academy, Kamphangpetch 6 Road, Laksi Bangkok, 10210 Thailand.
Chanisa ChotipanichNational Cyclotron and PET Centre, Chulabhorn Hospital, Chulabhorn Royal Academy, Kamphangpetch 6 Road, Laksi Bangkok, 10210 Thailand.
Chulabhorn Hospital · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A patient with intrahepatic cholangiocarcinoma who underwent hepatic resection with completed neoadjuvant chemotherapy presented with increased CEA levels. Previous whole abdominal and chest CT scan revealed no evidence of local recurrence or metastasis.

Indexed as

CholangiocarcinomaFDGFibroblast activation proteinIntraductal papillary mucinous neoplasm (IPMN)PET/CTPET/MRI

Identifiers

PMID34721719
PMCPMC8517048
OpenAlexW3194326878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.